tiprankstipranks
Trending News
More News >
Cardinal Health (CAH)
NYSE:CAH
US Market

Cardinal Health (CAH) Stock Forecast & Price Target

Compare
2,395 Followers
See the Price Targets and Ratings of:

CAH Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CAH Stock 12 Month Forecast

Average Price Target

$239.25
▲(11.34% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $239.25 with a high forecast of $270.00 and a low forecast of $209.00. The average price target represents a 11.34% change from the last price of $214.88.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"115":"$115","154":"$154","193":"$193","232":"$232","271":"$271"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$270.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":239.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$239.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":209,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$209.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[115,154,193,232,271],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,204.989,209.98984615384614,214.9906923076923,219.99153846153845,224.99238461538462,229.99323076923076,234.99407692307693,239.99492307692307,244.99576923076924,249.99661538461538,254.99746153846155,259.9983076923077,264.99915384615383,{"y":270,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,204.989,207.62446153846153,210.2599230769231,212.89538461538461,215.53084615384617,218.1663076923077,220.80176923076922,223.43723076923078,226.0726923076923,228.70815384615383,231.3436153846154,233.97907692307692,236.61453846153847,{"y":239.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,204.989,205.29753846153847,205.60607692307693,205.9146153846154,206.22315384615385,206.5316923076923,206.84023076923077,207.14876923076923,207.4573076923077,207.76584615384616,208.07438461538462,208.38292307692308,208.69146153846154,{"y":209,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":116.305,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.127,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.875,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.929,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.256,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.891,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.457,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.105,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.927,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 50, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.537,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 54, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.295,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 44, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.483,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":204.989,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$270.00Average Price Target$239.25Lowest Price Target$209.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CAH
Morgan Stanley
Morgan Stanley
$224$245
Buy
14.02%
Upside
Reiterated
01/29/26
Cardinal Health price target raised to $245 from $224 at Morgan StanleyCardinal Health price target raised to $245 from $224 at Morgan Stanley
TD Cowen
$225$233
Buy
8.43%
Upside
Reiterated
01/27/26
Cardinal Health price target raised to $233 from $225 at TD CowenCardinal Health price target raised to $233 from $225 at TD Cowen
Jefferies
$220$270
Buy
25.65%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)
Bank of America Securities Analyst forecast on CAH
Bank of America Securities
Bank of America Securities
$230$240
Buy
11.69%
Upside
Reiterated
01/15/26
Cardinal Health price target raised to $240 from $230 at BofACardinal Health price target raised to $240 from $230 at BofA
Wells Fargo Analyst forecast on CAH
Wells Fargo
Wells Fargo
$221$237
Buy
10.29%
Upside
Reiterated
01/15/26
Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Nuvation Bio (NUVB)
Robert W. Baird Analyst forecast on CAH
Robert W. Baird
Robert W. Baird
$232$250
Buy
16.34%
Upside
Reiterated
01/14/26
Cardinal Health price target raised to $250 from $232 at BairdCardinal Health price target raised to $250 from $232 at Baird
Evercore ISI
$220$250
Buy
16.34%
Upside
Reiterated
01/14/26
Cardinal Health (CAH) Gets a Buy from Evercore ISI
Leerink Partners Analyst forecast on CAH
Leerink Partners
Leerink Partners
$230$240
Buy
11.69%
Upside
Reiterated
01/13/26
Cardinal Health price target raised to $240 from $230 at LeerinkCardinal Health price target raised to $240 from $230 at Leerink
Citi
$190$244
Buy
13.55%
Upside
Upgraded
01/09/26
Cardinal Health upgraded to Buy from Neutral at CitiCardinal Health upgraded to Buy from Neutral at Citi
Mizuho Securities Analyst forecast on CAH
Mizuho Securities
Mizuho Securities
$202.95$210
Buy
-2.27%
Downside
Reiterated
12/22/25
Mizuho Securities Sticks to Their Buy Rating for Cardinal Health (CAH)
Barclays
$243
Buy
13.09%
Upside
Initiated
12/08/25
Cardinal Health initiated with an Overweight at BarclaysCardinal Health initiated with an Overweight at Barclays
J.P. Morgan Analyst forecast on CAH
J.P. Morgan
J.P. Morgan
$178$209
Hold
-2.74%
Downside
Reiterated
11/03/25
Cardinal Health (CAH) Gets a Hold from J.P. Morgan
UBS
$185$220
Buy
2.38%
Upside
Reiterated
10/31/25
Cardinal Health price target raised to $220 from $185 at UBSCardinal Health price target raised to $220 from $185 at UBS
Argus Research Analyst forecast on CAH
Argus Research
Argus Research
$185$189
Buy
-12.04%
Downside
Reiterated
08/22/25
Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CAH
Morgan Stanley
Morgan Stanley
$224$245
Buy
14.02%
Upside
Reiterated
01/29/26
Cardinal Health price target raised to $245 from $224 at Morgan StanleyCardinal Health price target raised to $245 from $224 at Morgan Stanley
TD Cowen
$225$233
Buy
8.43%
Upside
Reiterated
01/27/26
Cardinal Health price target raised to $233 from $225 at TD CowenCardinal Health price target raised to $233 from $225 at TD Cowen
Jefferies
$220$270
Buy
25.65%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Agios Pharma (NASDAQ: AGIO) and Henry Schein (NASDAQ: HSIC)
Bank of America Securities Analyst forecast on CAH
Bank of America Securities
Bank of America Securities
$230$240
Buy
11.69%
Upside
Reiterated
01/15/26
Cardinal Health price target raised to $240 from $230 at BofACardinal Health price target raised to $240 from $230 at BofA
Wells Fargo Analyst forecast on CAH
Wells Fargo
Wells Fargo
$221$237
Buy
10.29%
Upside
Reiterated
01/15/26
Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Nuvation Bio (NUVB)
Robert W. Baird Analyst forecast on CAH
Robert W. Baird
Robert W. Baird
$232$250
Buy
16.34%
Upside
Reiterated
01/14/26
Cardinal Health price target raised to $250 from $232 at BairdCardinal Health price target raised to $250 from $232 at Baird
Evercore ISI
$220$250
Buy
16.34%
Upside
Reiterated
01/14/26
Cardinal Health (CAH) Gets a Buy from Evercore ISI
Leerink Partners Analyst forecast on CAH
Leerink Partners
Leerink Partners
$230$240
Buy
11.69%
Upside
Reiterated
01/13/26
Cardinal Health price target raised to $240 from $230 at LeerinkCardinal Health price target raised to $240 from $230 at Leerink
Citi
$190$244
Buy
13.55%
Upside
Upgraded
01/09/26
Cardinal Health upgraded to Buy from Neutral at CitiCardinal Health upgraded to Buy from Neutral at Citi
Mizuho Securities Analyst forecast on CAH
Mizuho Securities
Mizuho Securities
$202.95$210
Buy
-2.27%
Downside
Reiterated
12/22/25
Mizuho Securities Sticks to Their Buy Rating for Cardinal Health (CAH)
Barclays
$243
Buy
13.09%
Upside
Initiated
12/08/25
Cardinal Health initiated with an Overweight at BarclaysCardinal Health initiated with an Overweight at Barclays
J.P. Morgan Analyst forecast on CAH
J.P. Morgan
J.P. Morgan
$178$209
Hold
-2.74%
Downside
Reiterated
11/03/25
Cardinal Health (CAH) Gets a Hold from J.P. Morgan
UBS
$185$220
Buy
2.38%
Upside
Reiterated
10/31/25
Cardinal Health price target raised to $220 from $185 at UBSCardinal Health price target raised to $220 from $185 at UBS
Argus Research Analyst forecast on CAH
Argus Research
Argus Research
$185$189
Buy
-12.04%
Downside
Reiterated
08/22/25
Cardinal Health price target raised to $189 from $185 at ArgusCardinal Health price target raised to $189 from $185 at Argus
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
xxx
Success Rate
13/17 ratings generated profit
76%
Average Return
+5.20%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +5.20% per trade.
1 Year
Success Rate
17/17 ratings generated profit
100%
Average Return
+30.49%
reiterated a buy rating 3 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.49% per trade.
2 Years
xxx
Success Rate
17/17 ratings generated profit
100%
Average Return
+69.18%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +69.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CAH Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
11
16
13
14
19
Hold
50
54
44
19
16
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
61
70
57
33
35
In the current month, CAH has received 19 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. CAH average Analyst price target in the past 3 months is 239.25.
Each month's total comprises the sum of three months' worth of ratings.

CAH Financial Forecast

CAH Earnings Forecast

Next quarter’s earnings estimate for CAH is $2.34 with a range of $2.15 to $2.54. The previous quarter’s EPS was $2.55. CAH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CAH has Performed in-line its overall industry.
Next quarter’s earnings estimate for CAH is $2.34 with a range of $2.15 to $2.54. The previous quarter’s EPS was $2.55. CAH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CAH has Performed in-line its overall industry.

CAH Sales Forecast

Next quarter’s sales forecast for CAH is $65.08B with a range of $63.99B to $66.92B. The previous quarter’s sales results were $64.01B. CAH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.09% of the time in the same period. In the last calendar year CAH has Performed in-line its overall industry.
Next quarter’s sales forecast for CAH is $65.08B with a range of $63.99B to $66.92B. The previous quarter’s sales results were $64.01B. CAH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.09% of the time in the same period. In the last calendar year CAH has Performed in-line its overall industry.

CAH Stock Forecast FAQ

What is CAH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 239.25.
    What is CAH’s upside potential, based on the analysts’ average price target?
    Cardinal Health has 11.34% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CAH a Buy, Sell or Hold?
          Cardinal Health has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Cardinal Health’s price target?
            The average price target for Cardinal Health is 239.25. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $270.00 ,the lowest forecast is $209.00. The average price target represents 11.34% Increase from the current price of $214.88.
              What do analysts say about Cardinal Health?
              Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of CAH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.